Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | TPMT | P51580 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.40 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.40 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24155 | 0.87 | ALDH1A1 (0.52) | CES2CES1MEN1KMT2ANPC1 | |
| SCHEMBL3361585 | 0.87 | CES2 (0.47) | CES2CES1MEN1KMT2AKDM4E | |
| SCHEMBL12020820 | 0.82 | LMNA (0.48) | CES2CES1MEN1KMT2ANPC1 | |
| SCHEMBL11914196 | 0.82 | ALDH1A1 (0.46) | CES2CES1MEN1KMT2ANPC1 | |
| SCHEMBL6738707 | 0.82 | TPMT (0.64) | CES2CES1MEN1KMT2ATPMT | |
| SCHEMBL10148964 | 0.81 | LMNA (0.50) | MEN1KMT2ATPMTKDM4EGAA | |
| SCHEMBL4360630 | 0.80 | TPMT (0.52) | CES2CES1ATMTPMTALDH1A1 | |
| SCHEMBL347092 | 0.80 | TPMT (0.59) | MEN1KMT2ATPMTGAAALDH1A1 | |
| SCHEMBL24653922 | 0.80 | BACE1 (0.46) | CES2CES1MEN1KMT2ANPC1 | |
| SCHEMBL19828394 | 0.80 | PARP1 (0.56) | CES2CES1MEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160060254-A1 | THIAZOLE-BASED INHIBITORS OF SCAVENGER RECEPTOR BI | THE BROAD INSTITUTE, INC. | 2016-03-03 | — | — | US | disclosed |
| US-20120172339-A1 | ANGIOGENIC RESORCINOL DERIVATIVES | NORTHEASTERN UNIVERSITY (US) | 2012-07-05 | — | — | US | disclosed |
| US-7875631-B2 | e.g.1-(3,5-dichlorophenyl)-2-formyl-6-methoxy-1,2,3,4-tetrahydroisoquinoline; to prevent and/or treat cancer and other abnormal cell growth, and metabolic as well as blood vessel proliferate disorders, in which uncontrolled expression of insulin-like growth factor-1 receptor is observed | ANALYTECON S.A. (CH) | 2011-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120172339-A1 | ANGIOGENIC RESORCINOL DERIVATIVES | CNR1, CNR2, KDR | CES2 783/4885CES1 653/4885MEN1 3629/4885 |
| US-20160060254-A1 | THIAZOLE-BASED INHIBITORS OF SCAVENGER RECEPTOR BI | SCARB1, HAVCR2, LDLR | CES2 302/4885CES1 31/4885MEN1 4786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.